Altimmune, Inc. ALT
Set alert
2.02 USD -0.02 -0.98%
At close · Nov 2
2.05 +0.03 +1.49%
After hours · Nov 2, 6:00 PM ET
2.01 Day range 2.11
1.99 52-week range 6.44
- YTD
- -44.04%
- 1 year
- -50.12%
- Open
- 2.07
- Prev close
- 2.04
- Mkt cap
- 392.93M
- Vol
- 2.74M
- Avg vol
- 4.04M
- EPS
- -0.76
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.01
- High
- 2.11
- Forward P/E
- -5.14
- Beta
- 0.07
- Short ratio
- 5.81
- Inst. own
- 56.68%
- Dividend
- 0.00
- Ex-div date
- Jan 19, 2017
- 50-d avg
- 7.91
- 200-d avg
- 7.41
- 1y target
- 22.86
5D chart
Signals (63)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 1:25 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 1:10 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 1:10 PM | 10 hours ago |
| MACD: Buy Signal | Nov 2, 12:55 PM | 10 hours ago |
| MACD: Sell Signal | Nov 2, 12:25 PM | 11 hours ago |
| MACD: Buy Signal | Nov 2, 12:00 PM | 11 hours ago |
| MACD: Sell Signal | Nov 2, 11:55 AM | 11 hours ago |
| MACD: Buy Signal | Nov 2, 11:50 AM | 12 hours ago |
| SMA: Bullish | Nov 2, 11:30 AM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 10:30 AM | 13 hours ago |
| SMA: Bearish | Nov 2, 10:15 AM | 13 hours ago |
| MACD: Buy Signal | Oct 30, 2:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:15 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:10 PM | 3 days ago |
| RSI: Oversold | Oct 30, 1:50 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 1:25 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 12:45 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:40 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:40 PM | 3 days ago |
Newest 20 of 63.
Financial health
Altman Z-Score
2.81 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
Valuation
P/E -3.6×
FY 2016 5y median -5.4× FY 2025
P/S 7757×
FY 2016 5y median 1406× FY 2025
P/B 1.4×
FY 2016 5y median 3.1× FY 2025
P/FCF -4.7×
FY 2016 5y median -6.4× FY 2025
EV/EBITDA -3.6×
FY 2016 5y median -5.0× FY 2025
EV/Sales 7561×
FY 2016 5y median 1091× FY 2025
FCF Yield -21.2%
FY 2016 5y median -15.6% FY 2025
Profitability
Gross Margin 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -230461.0%
FY 2016 5y median -22518.5% FY 2025
Net Margin -214861.0%
FY 2016 5y median -20762.2% FY 2025
ROE -39.2%
FY 2016 5y median -45.7% FY 2025
ROIC -35.4%
FY 2016 5y median -48.2% FY 2025
ROA -31.5%
FY 2016 5y median -42.0% FY 2025
Growth (YoY)
Revenue 105.0%
FY 2016 FY 2025
Operating Income 8.4%
FY 2016 FY 2025
EPS (diluted) 25.4%
FY 2016 FY 2025
Free Cash Flow 15.4%
FY 2016 FY 2025
Financial Health
Current Ratio 18.5×
FY 2016 5y median 13.1× FY 2025
Quick Ratio 18.5×
FY 2016 5y median 13.1× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016 5y median 1.3× FY 2025
Interest Coverage -57.8×
FY 2016 5y median -10968× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
